Laszlo Kiss is Executive Director at Pfizer Ventures. Laszlo is responsible for identifying, evaluating, making and managing equity investments aligned with the future directions of Pfizer, with a current emphasis on neuroscience. Laszlo has over 20 years of drug discovery, development and management experience. He has a successful track record in leading CNS, CV and Rare Disease drug discovery programs from early exploratory research through clinical development. Prior to joining Pfizer, Laszlo held various roles of increasing responsibility at Bristol-Myers Squibb, Essen Biosciences and Merck & Co. Laszlo earned his Ph.D. in Physiology and Neurobiology from the University of Connecticut and completed his post-doctoral training in Neuroscience at the University of California at San Diego. He is the author of more than 50 scientific publications in peer reviewed journals, book chapters, abstracts and patents. Laszlo has served on grant review panels at the National Institutes of Health, National Institute of Neurological Disorders and Stroke.